Kucera Pharmaceutical Co. Inc.
|
|
|
|
|
proprietary small molecule platform consists of over 100 patented synthetic compounds- DEAC? are designed to significantly improve the profiles of many antiviral; anticancer and potentially CNS drugs | |
Korean Distributor : ??? |
Products information :
|
|
|
|
|
|
|
|
|
|